Response to Intravenous Lidocaine in a Patient with SUNCT Syndrome

Short-lasting unilateral neuralgiform headache with conjunctival injection and tearing (SUNCT) syndrome represents a serious therapeutic and diagnostic challenge, since it is usually refractory to most drugs and lacks biological markers. Response to intravenous lidocaine administration has been repo...

Full description

Saved in:
Bibliographic Details
Published in:Cephalalgia 2010-01, Vol.30 (1), p.110-112
Main Authors: Arroyo, A Martinez, Durán, X Romero, Beldarrain, M Gomez, Pinedo, A, García-Moncó, JC
Format: Article
Language:English
Subjects:
Aged
Anesthetics, Local - administration & dosage
Humans
Injections, Intravenous
Lidocaine - administration & dosage
Male
Recurrence
Remission Induction
SUNCT Syndrome - drug therapy
Citations: Items that this one cites
Items that cite this one
Online Access:Request full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Short-lasting unilateral neuralgiform headache with conjunctival injection and tearing (SUNCT) syndrome represents a serious therapeutic and diagnostic challenge, since it is usually refractory to most drugs and lacks biological markers. Response to intravenous lidocaine administration has been reported in some patients while it has failed in others. We report a patient with SUNCT syndrome who showed a clear-cut and consistent response to intravenous lidocaine therapy, which proved superior to placebo in a single-blinded fashion. Intravenous lidocaine should be considered in all patients with SUNCT syndrome. Response to this therapy could represent a diagnostic tool.
ISSN:0333-1024
1468-2982
DOI:10.1111/j.1468-2982.2009.01871.x